South Africa holds off AstraZeneca vaccination over doubts on its effectiveness against coronavirus variant
South Africa has decided to hold off the Covid-19 vaccination drive using AstraZeneca vaccine following a national research over its effectiveness against South African coronavirus variant.
South Africa will give the unapproved Johnson & Johnson vaccine to its front-line health workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant there, the health minister said Wednesday.
JOHANNESBURG, Feb 8: South Africa has suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a small clinical trial suggested that it isn’t effective in preventing mild to moderate illness from the variant dominant in the country.
_20210208091816.jpeg)